alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         We, Barry Willson and Gary Rodney, certify that:

1. We have reviewed this quarterly report on Form 10-QSB of Xstream Beverage
Group, Inc.

2. Based on our knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on our knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. We are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
registrant and we have:

         a) Designed such disclosure controls and procedures to ensure that
material information relating to the registrant, particularly during the period
in which this quarterly report is being prepared;

         b) Evaluated the effectiveness of the registrant's disclosure controls
and procedures as of a date within 90 days prior to the filing date of this
quarterly report (the AEvaluation Date@); and

         c) Presented in this quarterly report our conclusions about the
effectiveness of the disclosure controls and procedures based on our evaluation
as of the Evaluation Date;

5. We have disclosed, based on our most recent evaluation, to the registrant's
auditors and the audit committee of registrant's board of directors (or persons
performing the equivalent function):

         a) All significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and

         b) Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's internal
controls; and

<PAGE>

6. We have indicated in this quarterly report whether or not there were
significant changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of our most recent
evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.

Date:  August 14, 2003

/s/ Barry Willson
-----------------
By:  Barry Willson
---

Exhibit 99.9

Consent of Jeffrey Volk

I consent to the inclusion in this annual report on Form 40-F of AuRico Gold Inc., which is being filed with the United States Securities and Exchange Commission, of references to my name in connection with the following reports and documents,
included in the 2012 Annual Information Form of AuRico Gold Inc., dated April 1, 2013 (the “AIF”):

Sections 6, 7, 8, 9, 10, 11, 13 and 23 of the NI 43-101 Technical Report for the Kemess Underground Project, British Columbia, Canada

Dec 31st, 2012, Young-Davidson Resources

Dec 31st, 2012, Kemess Underground Resources

Dec 31st, 2012, Orion Resource

I also consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-177638, File No. 333-175079 and File No. 333-173458 ) and in the Registration Statement on Form F-10 (File No. 333-177404) of the references to my name and the above-mentioned information in the AIF.

Dated this 1st day of April, 2013.

/s/ Jeffrey VolkBy: Jeffrey Volk, FAusIMM, CPG 
       Title: Director, Reserves and Resources 
       Company: AuRico Gold Inc.

---
# Official Journal C 447/29 D

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 447 |
| | |
| English edition | Information and Notices | Volume 6029 December 2017 |

ISSN 1977-091X

Official Journal

of the European Union

C 447

English edition

Information and Notices

Volume 6029 December 2017

---

| Notice No | Contents | page |
| --- | --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2017/C 447/01 | Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 November 2017 to 30 November 2017(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council) | 1 |
| 2017/C 447/02 | Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 November 2017 to 30 November 2017(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC) | 11 |

Notice No

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2017/C 447/01

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 November 2017 to 30 November 2017(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

1

2017/C 447/02

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 November 2017 to 30 November 2017(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

11

---

| | Corrigenda |
| --- | --- |
| 2017/C 447/03 | Corrigendum to the Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 August 2016 to 31 August 2016 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council) ( OJ C 362, 30.9.2016 ) | 110 |

Corrigenda

2017/C 447/03

Corrigendum to the Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 August 2016 to 31 August 2016 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council) ( OJ C 362, 30.9.2016 )

( OJ C 362, 30.9.2016 )

110

---

| EN | |
| --- | --- |

EN
# L_2009130EN.01002201.xml

| 28.5.2009 | EN | Official Journal of the European Union | L 130/22 |
| --- | --- | --- | --- |

28.5.2009

EN

Official Journal of the European Union

L 130/22

---

DECISION OF THE EEA JOINT COMMITTEE

No 29/2009

of 17 March 2009

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

Whereas:

| (1) | Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 49/2008 of 25 April 2008 (1). |
| --- | --- |

(1)

Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 49/2008 of 25 April 2008 (1).

| (2) | Commission Directive 2008/14/EC of 15 February 2008 amending Council Directive 76/768/EEC, concerning cosmetic products, for the purpose of adapting Annex III thereto to technical progress (2) is to be incorporated into the Agreement, |
| --- | --- |

(2)

Commission Directive 2008/14/EC of 15 February 2008 amending Council Directive 76/768/EEC, concerning cosmetic products, for the purpose of adapting Annex III thereto to technical progress (2) is to be incorporated into the Agreement,

HAS DECIDED AS FOLLOWS:

Article 1

The following indent shall be added in point 1 (Council Directive 76/768/EEC) of Chapter XVI of Annex II to the Agreement:

| ‘— | 32008 L 0014: Commission Directive 2008/14/EC of 15 February 2008 (OJ L 42, 16.2.2008, p. 43).’ |
| --- | --- |

‘—

32008 L 0014: Commission Directive 2008/14/EC of 15 February 2008 (OJ L 42, 16.2.2008, p. 43).’

Article 2

The text of Directive 2008/14/EC in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 18 March 2009, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 17 March 2009.

For the EEA Joint Committee

The President

Alan SEATTER

---

(1)  
  OJ L 223, 21.8.2008, p. 45.

1

(2)  
  OJ L 42, 16.2.2008, p. 43.

2

(*1)  No constitutional requirements indicated.

*1

---
In the Matter of DISBARMENT OF Francis Joseph COYLE, Jr.

No. D-2991.

Supreme Court of the United States

Aug. 25, 2017.

Disbarment order entered.
Release: #4000-97 (CFTC Docket No. SD 97-2)
     For Release: March 7, 1997CFTC FILES STATUTORY DISQUALIFICATION ACTION AGAINST JAMES P. GRAEBER,
    JR. AND SIMULTANEOUSLY ACCEPTS HIS OFFER, WHICH INCLUDES A TWO YEAR PERIOD
    OF RESTRICTED REGISTRATION
     WASHINGTON -- The Commodity Futures Trading Commission (CFTC) announced
    today that it has filed a Notice of Intent to Suspend, Revoke or
    Restrict Registration against James P. Graeber, Jr., of
    Naperville, Illinois, a registered floor broker. At the same time the
    Notice was filed, the CFTC accepted Graeber's offer of settlement, which
    restricts Graeber's floor broker registration for a two-year period.
     Under the terms of the settlement, during the two-year period of
    restricted registration Graeber will be prohibited from acting as a
    registrant unless he obtains a sponsor who will closely supervise his
    activities. In addition, Graeber may not:

-- 1) act as a principal, partner, officer, or branch office manager of
    any entity required to be registered with the Commission;

-- 2) act as a supervisor over anyone require to be registered;

-- 3) exercise discretionary authority over orders (with limited
    exceptions); or

-- 4) serve on certain self-regulatory committees, including
    disciplinary committees, arbitration panels, and governing boards.
     The CFTC's Notice alleged that Graeber was statutorily disqualified from
    registration as a result of a November 1994 felony conviction for reckless
    homicide and a 1980 conviction for misdemeanor theft.
Exhibit 10.1

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350
     AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

          In connection with the annual report on Form 20-F of MIH Limited, a
company organized under the laws of the British Virgin Islands (the
"Company"), for the period ending March 31, 2002 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), each of the
undersigned officers of the Company certify pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to
such officer's knowledge and belief, that:

          1.) the Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

          2.) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company as of March 31, 2002 (the last date of the period covered by the
Report).




Dated:  October 25, 2002              /s/ Jacobus D.T. Stofberg
                                      -------------------------
                                      Jacobus D.T. Stofberg
                                      Chief Executive Officer



Dated:  October 25, 2002              /s/ Stephen F. Ward
                                      --------------------------
                                      Stephen F. Ward
                                      Chief Financial Officer
Craig Kendall GIBONEY, petitioner, v. UNITED STATES.

No. 17-6576.

Supreme Court of the United States

Dec. 4, 2017.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
Igor OLENICOFF, et al., petitioners, v. Donald WAKEFIELD.

No. 17-56.

Supreme Court of the United States

Oct. 2, 2017.

*212Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
# L_2014198DE.01001402.xml

| 5.7.2014 | DE | Amtsblatt der Europäischen Union | L 198/14 |
| --- | --- | --- | --- |

5.7.2014

DE

Amtsblatt der Europäischen Union

L 198/14

---

Berichtigung des Beschlusses des Gemeinsamen EWR-Ausschusses Nr. 160/2013 vom 8. Oktober 2013 zur Änderung von Anhang II (Technische Vorschriften, Normen, Prüfung und Zertifizierung) des EWR-Abkommens

(
  Amtsblatt der Europäischen Union L 58 vom 27. Februar 2014
  )

(
  Amtsblatt der Europäischen Union L 58 vom 27. Februar 2014

Auf Seite 13, Erwägungsgrund 1:

anstatt:

„Die Richtlinie 2012/26/EU des Europäischen Parlaments und des Rates vom 25. Oktober 2012 zur Änderung der Richtlinie 2001/83/EG hinsichtlich der Impfung gegen die Blauzungenkrankheit (1) ist in das EWR-Abkommen aufzunehmen.“

muss es heißen:

„Die Richtlinie 2012/26/EU des Europäischen Parlaments und des Rates vom 25. Oktober 2012 zur Änderung der Richtlinie 2001/83/EG hinsichtlich der Pharmakovigilanz (1) ist in das EWR-Abkommen aufzunehmen.“

---
```
  
 
VIX FUTURES - CBOE FUTURES EXCHANGE                                  Code-1170E1
OPTION AND FUTURES COMBINED POSITIONS AS OF 08/18/09          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
($1000 X INDEX)                                      OPEN INTEREST:       41,567
COMMITMENTS
   6,616    5,950    2,563   23,974   27,325   33,153   35,838    8,414    5,729

CHANGES FROM 08/11/09 (CHANGE IN OPEN INTEREST:        612)
     -18      826   -2,143    2,994    1,367      833       50     -221      562

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
    15.9     14.3      6.2     57.7     65.7     79.8     86.2     20.2     13.8

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:       27)
       8        8        8       11        8       24       19
```

----

Updated August 21, 2008
# L_2013291EN.01006301.xml

| 31.10.2013 | EN | Official Journal of the European Union | L 291/63 |
| --- | --- | --- | --- |

31.10.2013

EN

Official Journal of the European Union

L 291/63

---

DECISION OF THE EEA JOINT COMMITTEE

No 97/2013

of 3 May 2013

amending Annex XXI (Statistics) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Implementing Regulation (EU) No 81/2013 of 29 January 2013 amending Implementing Regulation (EU) No 1051/2011 as regards the micro-data files for the transmission of data (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Implementing Regulation (EU) No 81/2013 of 29 January 2013 amending Implementing Regulation (EU) No 1051/2011 as regards the micro-data files for the transmission of data (1) is to be incorporated into the EEA Agreement.

| (2) | Annex XXI to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex XXI to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following is added in point 7ca (Commission Implementing Regulation (EU) No 1051/2011) of Annex XXI to the EEA Agreement:

‘, as amended by:

| — | 32013 R 0081: Commission Implementing Regulation (EU) No 81/2013 of 29 January 2013 (OJ L 28, 30.1.2013, p. 1).’. |
| --- | --- |

—

32013 R 0081: Commission Implementing Regulation (EU) No 81/2013 of 29 January 2013 (OJ L 28, 30.1.2013, p. 1).’.

Article 2

The text of Implementing Regulation (EU) No 81/2013 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 4 May 2013, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 3 May 2013.

For the EEA Joint Committee

The President

Gianluca GRIPPA

---

(1)  
  OJ L 28, 30.1.2013, p. 1.

1

(*1)  No constitutional requirements indicated.

*1

---
Walter Alston BROWN, Jr., petitioner, v. UNITED STATES.

No. 16-9747.

Supreme Court of the United States

Nov. 27, 2017.

On petition for writ of certiorari to the United States Court of Appeals for the Third Circuit. Motion of petitioner for leave to proceed *in forma pauperis* and petition for writ of certiorari granted. Judgment vacated, and case remanded to the United States Court of Appeals for the Third Circuit for further consideration in light of *Honeycutt v. United States,* 581 U.S. ----, 137 S.Ct. 1626, 198 L.Ed.2d 73 (2017).
# Official Journal C 91A/26 A

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 91A |
| | |
| English edition | Information and Notices | Volume 5026 April 2007 |

ISSN 1725-2423

Official Journal

of the European Union

C 91A

English edition

Information and Notices

Volume 5026 April 2007

---

| Notice No | Contents | page |
| --- | --- | --- |
| | |
| 2007/C 091A/01 | NOTICE TO READERS | 1 |

Notice No

Contents

page

2007/C 091A/01

NOTICE TO READERS

1

---

| | V   Announcements |
| --- | --- |
| | ADMINISTRATIVE PROCEDURES |
| | European Personnel Selection Office (EPSO) |
| 2007/C 091A/02 | Reserve list — Open competition EPSO/AD/29/05 — Administrators (AD5) — In the field of Economics/statistics | 3 |
| 2007/C 091A/03 | Reserve list — Open competition EPSO/AST/7/05 — Assistants (AST3) — In the field 1 ‘financial management/accountancy’ | 6 |

V   Announcements

ADMINISTRATIVE PROCEDURES

European Personnel Selection Office (EPSO)

2007/C 091A/02

Reserve list — Open competition EPSO/AD/29/05 — Administrators (AD5) — In the field of Economics/statistics

3

2007/C 091A/03

Reserve list — Open competition EPSO/AST/7/05 — Assistants (AST3) — In the field 1 ‘financial management/accountancy’

6

---

| EN | |
| --- | --- |

EN
# L_2013081EN.01003601.xml

| 21.3.2013 | EN | Official Journal of the European Union | L 81/36 |
| --- | --- | --- | --- |

21.3.2013

EN

Official Journal of the European Union

L 81/36

---

DECISION OF THE EEA JOINT COMMITTEE

No 234/2012

of 31 December 2012

amending Annex XX (Environment) to the EEA Agreement

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Regulation (EU) No 600/2012 of 21 June 2012 on the verification of greenhouse gas emission reports and tonne-kilometre reports and the accreditation of verifiers pursuant to Directive 2003/87/EC of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Regulation (EU) No 600/2012 of 21 June 2012 on the verification of greenhouse gas emission reports and tonne-kilometre reports and the accreditation of verifiers pursuant to Directive 2003/87/EC of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement.

| (2) | Annex XX to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex XX to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following point is inserted after point 21ape (Commission Regulation (EU) No 606/2010) of Annex XX to the EEA Agreement:

| ‘21apf. | 32012 R 0600: Commission Regulation (EU) No 600/2012 of 21 June 2012 on the verification of greenhouse gas emission reports and tonne-kilometre reports and the accreditation of verifiers pursuant to Directive 2003/87/EC of the European Parliament and of the Council (OJ L 181, 12.7.2012, p. 1).’. |
| --- | --- |

‘21apf.

Article 2

The text of Regulation (EU) No 600/2012 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 1 January 2013, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 31 December 2012.

For the EEA Joint Committee

The President

Atle LEIKVOLL

---

(1)  
  OJ L 181, 12.7.2012, p. 1.

1

(*1)  No constitutional requirements indicated.

*1

---
<PAGE>

                                                                    Exhibit 10.5

                                    AGREEMENT
                                       TO
                           HOLD HARMLESS AND INDEMNIFY

                  Agreement made this 2nd day of September, 1999, by and between
U.S. Medical Alliance, a Delaware Corporation, and its successor in interest
I-Trax.com, also a Delaware Corporation (collectively, "UMAI"); and Member-Link
Systems, Inc., a Delaware corporation ("MLS").

                  UMAI and MLS have agreed to enter into various arrangements
and joint business activities, as evidenced by other agreements being made
between them contemporaneously with this one. Except for the discussions leading
up to these arrangements, which have proceeded for approximately 30 days prior
to this Agreement, MLS and UMAI have had no previous dealings, business
arrangements, investment in each other, or joint activities of any kind
whatsoever.

                  Therefore, as part of its consideration for the contribution
by MLS of its licenses and other things of value, UMAI hereby agrees to hold
harmless, indemnify and defend MLS, its officers, directors, employees and
shareholders, from and against any losses, claims, lawsuits, damages,
liabilities, fines and expenses (including attorneys' fees and costs) arising
out of or relating to any activities, transactions, litigation, contracts, or
securities matters involving UMAI that may have or are alleged to have occurred
prior to the closing date of the transfer of equity consideration to MLS. This
provision includes in its scope but is not limited to, any activities,
transactions, litigation, contracts or securities matters conducted under either
of the names attributed above to UMAI, or otherwise involving them.

                  UMAI, and the undersigned on its behalf, represents and
warrants that it has full legal rights, power and authority to make the
foregoing Agreement, and that this Agreement is legal, valid and binding, and
enforceable against it in accordance with its terms.

Signed: /s/ Frank A. Martin                              Date: September 2, 1999
        ------------------------------------------             -----------------
        Frank A. Martin, President & Chairman
        U.S. Medical Alliance and I-Trax.com


Signed: /s/ Hans C. Kastensmith                          Date: September 2, 1999
        -----------------------------------------              -----------------
        Hans C. Kastensmith, President & Chairman
        Member-Link Systems, Inc.

                                        1